ANTITUMOR-ACTIVITY OF IONIC NIOBOCENE AND MOLYBDENOCENE COMPLEXES IN HIGH OXIDATION-STATES

被引:44
作者
KOPFMAIER, P [1 ]
KLAPOTKE, T [1 ]
机构
[1] TECH UNIV BERLIN,INST ANORGAN & ANALYT CHEM,W-1000 BERLIN 12,GERMANY
关键词
NIOBOCENE COMPLEXES; MOLYBDENOCENE COMPLEXES; IONIC METALLOCENE DERIVATIVES; ANTITUMOR AGENTS; EHRLICH ASCITES TUMOR;
D O I
10.1007/BF01410137
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Four air-stable niobocene complexes [(C5H5)2NbCl2]+X- with X = BF4, AsF6, SbF6, SO3CF3 and the molybdenocene derivative [C5H5)2MoCl2]2+[SbF6]2- were investigated for antitumor properties against Ehrlich ascites tumor in female CF1 mice. All compounds are new, salt-like complexes containing a cationic metallocene moiety, where the early transition metals niobium and molybdenum in the high oxidation states +5 and +6 function as central atoms. The niobocene complexes containing tetrafluoroborate (BF4-) or trifluoromethanesulfonate (CF3SO3-) as anions only induced a maximal cure rate of 50% and led to increases in life span of 182% and 178% following application of optimal doses. The other two niobocene compounds with hexafluoroarsenate (AsF6-) and hexafluoroantimonate (SbF6-) as anions and the molybdenocene derivative (C5H5)2MoCl2]2+[SbF6]2- effected a maximal cure rate of 100% and increases in life span of 346%, 376%, and 332%, respectively, determined on the key date, i.e., on day 90 after transplantation. On applying the niobocene hexafluoroantimonate complex [(C5H5)2NbCl2] +[SbF6]-, the optimal dose range with a cure rate of 100% was rather broad and extended from 20 mg/kg to 40 mg/kg. Correspondingly, the value of the therapeutic index (TI) was high and amounted to 7.2. In the case of the niobocene hexafluoroarsenate and the molybdenocene hexafluoroantimonate complexes, the TI value decreased to 5.3 and 2.6 respectively. Neither impairments of the general condition nor any conspicuous symptoms could be detected after application of therapeutic doses of the five compounds investigated. Compared to the neutral niobocene dichloro complex [(C5H5)2NbCl2], the therapeutic range of the ionic niobocene derivative [(C5H5)2NbCl2]+[SbF6]- was broadened, the TI value markedly elevated from 2.9 to 7.2, and the toxic symptoms were impressively reduced. The niobocene hexafluoroantimonate complex was the most effective compound investigated in the present study.
引用
收藏
页码:216 / 221
页数:6
相关论文
共 23 条
[1]   STRUCTURAL STUDIES OF (PI-C5H5)2MX2 COMPLEXES AND THEIR DERIVATIVES - STRUCTURE OF BIS(PI-CYCLOPENTADIENYL)TITANIUM DICHLORIDE [J].
CLEARFIELD, A ;
WARNER, DK ;
SALDARRIAGAMOLINA, CH ;
ROPAL, R ;
BERNAL, I .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1975, 53 (11) :1622-1629
[2]   ORGANO TRANSITION-METAL CHEMISTRY OF HIGHLY FLUORINATED LIGAND SYSTEMS .10. NEW ORGANONIOBIUM(V)PERFLUOROBORATE, ORGANONIOBIUM(V)PERFLUOROARSENATE AND ORGANONIOBIUM(V)PERFLUOROANTIMONATE COMPLEXES [J].
GOWIK, P ;
KLAPOTKE, T .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1989, 368 (01) :35-44
[3]   DICATIONS OF MOLYBDENOCENE(VI) AND TUNGSTENOCENE(VI) DICHLORIDES [J].
GOWIK, P ;
KLAPOTKE, T ;
WHITE, P .
CHEMISCHE BERICHTE, 1989, 122 (09) :1649-1650
[4]   METALLOCENE CHEMISTRY OF HIGHLY FLUORIDATED LIGAND SYSTEMS .11. SYNTHESIS AND CHARACTERIZATION OF CP2TI(SBF6)2 AND CP2TI(SB2F11)2 - STRUCTURE OF CP2TI(SBF6)2 AND CP2V(SBF6)2 [J].
GOWIK, P ;
KLAPOTKE, T ;
THEWALT, U .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1990, 385 (03) :345-350
[5]   QUANTITATIVE OXIDATION OF ORGANOVANADIUM(IV) AND ORGANONIOBIUM(IV) COMPLEXES - SYNTHESIS OF CP2V(SBF6)2, [CP2VCL2][ASF6], AND [CP2V(ASF6)2][ASF6] - CRYSTAL-STRUCTURE OF [CP2NBCL2][SBF6] [J].
GOWIK, P ;
KLAPOTKE, T ;
PICKARDT, J .
ORGANOMETALLICS, 1989, 8 (12) :2953-2956
[6]   BONDING MODEL FOR BENT BIS-(PI-CYCLOPENTADIENYL) METAL-COMPOUNDS [J].
GREEN, JC ;
GREEN, MLH ;
PROUT, CK .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1972, (07) :421-&
[7]   BIS(ETA-5-CYCLOPENTADIENYL)BIS(HEXAFLUOROARSENATO) TITANIUM(IV) - SYNTHESIS, CHARACTERIZATION AND STRUCTURE [J].
KLAPOTKE, T ;
THEWALT, U .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1988, 356 (02) :173-179
[8]   TITANOCENE DICHLORIDE - 1ST METALLOCENE WITH CANCEROSTATIC ACTIVITY [J].
KOPF, H ;
KOPFMAIER, P .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1979, 18 (06) :477-478
[9]  
Kopf-Maier P., 1989, PROG CLIN BIOCH MED, V10, P151
[10]  
Kopf-Maier P., 1988, STRUCT BOND, V70, P103